Brief Research Report
Published on 03 Apr 2023
Evaluation of early left-sided cardiac reverse remodeling under combined therapy of sacubitril-valsartan and spironolactone compared with angiotensin-converting enzyme inhibitors and spironolactone
in Heart Failure and Transplantation

- 2,205 views
- 3 citations